La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « Keywords » - entrée « Treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Trauma < Treatment < Treatment efficiency  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 285.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000000 (2014) Alexandro Gianforcaro [Canada] ; Mazen J. Hamadeh [Canada]Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
000005 (2014) Michel Panisset [Canada] ; Jack J. Chen [États-Unis] ; Sean H. Rhyee [États-Unis] ; Jill Conner [États-Unis] ; Julie Mathena [États-Unis]Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
000006 (2014) Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
000043 (2013) Roger S. Mcintyre [Canada] ; Alissa M. Powell [Canada] ; Oksana Kaidanovich-Beilin [Canada] ; Joanna K. Soczynska [Canada] ; Mohammad Alsuwaidan [Canada] ; Hanna O. Woldeyohannes [Canada] ; Ashley S. Kim [Canada] ; L. Ashley Gallaugher [Canada]The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
000044 (2013) James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
000049 (2013) Nir Lipsman [Canada] ; D. Blake Woodside [Canada] ; Peter Giacobbe [Canada] ; Clement Hamani [Canada] ; Jacqueline C. Carter [Canada] ; Sarah Jane Norwood [Canada] ; Kalam Sutandar [Canada] ; Randy Staab [Canada] ; Gavin Elias [Canada] ; Christopher H. Lyman [États-Unis] ; Gwenn S. Smith [États-Unis] ; Andres M. Lozano [Canada]Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial
000060 (2013) Abdul Qayyum Rana [Canada] ; Ishraq Siddiqui [Canada] ; Masood Zangeneh [Canada] ; Abdul Fattah [Canada] ; Naeem Awan [Canada] ; Muhammad Saad Yousuf [Canada]Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients
000065 (2013) Susan H. Fox [Canada]Non-dopaminergic Treatments for Motor Control in Parkinson's Disease
000068 (2013) Danielle Murray [Canada] ; A. Jon Stoessl [Canada]Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
000128 (2012) Chaim M. Bell [Canada] ; Stacey S. Brener [Canada] ; Rebecca Comrie [Canada] ; Geoffrey M. Anderson [Canada] ; Susan E. Bronskill [Canada]Quality Measures for Medication Continuity in Long-Term Care Facilities, Using a Structured Panel Process
000142 (2012) Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France]Long-Term Outcomes of Surgical Therapies for Parkinson's Disease
000145 (2012) Alan C. Jackson [Canada]Is minocycline useful for therapy of acute viral encephalitis?
000169 (2012) Yusuke Iwata [Japon] ; Sachiko Irie [Japon] ; Hiroyuki Uchida [Japon, Canada] ; Takefumi Suzuki [Japon] ; Koichiro Watanabe [Japon] ; Satoru Iwashita [Japon] ; Masaru Mimura [Japon]Effects of zonisamide on tardive dyskinesia: A preliminary open-label trial
000190 (2012) Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] ; Renato P. Munhoz [Brésil] ; Katia Charland [Canada] ; Amelie Pelletier [Canada] ; Mariana Moscovich [Brésil] ; Luciane Filla [Brésil] ; Debora Zanatta [Brésil] ; Silvia Rios Romenets [Canada] ; Robert Altman [Canada] ; Rosa Chuang [Canada] ; Binit Shah [Canada]Caffeine for treatment of Parkinson disease: A randomized controlled trial
000215 (2011) Penny A. Macdonald [Canada] ; Alex A. Macdonald [Canada] ; Ken N. Seergobin [Canada] ; Ruzbeh Tamjeedi [Canada] ; Hooman Ganjavi [Canada] ; Jean-Sebastien Provost [Canada] ; Oury Monchi [Canada]The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI
000217 (2011) Klaus Seppi ; Daniel Weintraub ; Miguel Coelho ; Santiago Perez-Lloret ; Susan H. Fox ; Regina Katzenschlager ; Eva-Maria Hametner ; Werner Poewe [Autriche] ; Olivier Rascol ; Christopher G. Goetz ; Cristina SampaioThe Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
000218 (2011) Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease
000225 (2011) Amit Bar-Or [Canada] ; Peter Rieckmann [Canada] ; Anthony Traboulsee [Canada] ; V. Wee Yong [Canada]Targeting Progressive Neuroaxonal Injury: Lessons from Multiple Sclerosis
000228 (2011) Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada]Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion
000235 (2011) Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada]Predictors of Time to Requiring Dopaminergic Treatment in 2 Parkinson's Disease Cohorts
000237 (2011) C. Gibrat [Canada] ; F. Cicchetti [Canada]Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases : THE NEUROBIOLOGY OF NEURODEGENERATIVE DISORDER: FROM BASIC TO CLINICAL RESEARCH

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Treatment" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Treatment
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022